2014]Hydroxycut-induced Liver Toxicity
And like California, other states have proposed cutting coverage for obesity medications or have already done so, whether in the Medicaid program itself or state employee plans
[53] The trials were conducted at 673 sites in 24 countries, including Argentina, Australia, Brazil, Canada, India, Israel, Japan, Mexico, Russian Federation, South Korea, Taiwan, European Union, and the United States (including Puerto Rico)
It is also chosen by those who are unable to use the FDA-approved versions due to specific health reasons or other factors like allergic to any component of the drug (for example, dye)) or inability to take the drug in solid oral form such as tablets or capsule (which often occurs in children and elders), or if the physicians believe that the drug is not medically appropriate to treat the patient